Farzaneh Hosseini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Farzaneh Hosseini has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Ali Mojtahedi
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 shared publications - Maryam Bikhof Torbati
Department of Biology, YI.C., Islamic Azad University, Tehran, Iran
2 shared publications - Milad Shahsavari
Department of Biology, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University
2 shared publications - Mohamad Reza Razavi
Pasteur Institute of Iran
2 shared publications - Samaneh Kazemi
Deputy of Research and Technology, Guilan University of Medical Sciences, Rasht, Iran
2 shared publications - Sedigheh Arbabian
Department of Biology, NT.C., Islamic Azad University, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 27 (1)
Association of IL-8 and IL-8R1 gene polymorphisms with COVID-19 mortality
Background: Host genetic factors contribute to the heterogeneity of clinical outcomes in Coronavirus Disease 2019 (COVID-19). Interleukin-8 (IL-8) and its receptor IL-8R1 (CXCR1) play key roles in inflammatory responses and cytokine-mediated tissue damage during severe SARS-CoV-2 infection. This study investigated the association of IL-8 rs4073 and rs2227306, as well as IL-8R1 rs2234671 polymorphisms, with COVID-19 mortality in an Iranian population. Methods: A total of 328 hospitalized COVID-19 patients, including 178 recovered and 150 deceased individuals, were enrolled. Genotyping of IL-8 rs4073, IL-8 rs2227306, and IL-8R1 rs2234671 polymorphisms was performed using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP), and selected samples were confirmed by Sanger sequencing. Genotype and allele frequencies were compared between groups, and logistic regression models were applied to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Multilocus genotype combination analysis was also conducted. Results: The IL-8R1 rs2234671 polymorphism showed a significant association with COVID-19 mortality. Carriers of the G allele exhibited an increased risk of death compared with CC homozygotes under codominant, dominant, overdominant, and log-additive inheritance models (all P < 0.05). The strongest association was observed under the dominant model (OR = 3.29, 95% CI = 1.55–6.99, P = 0.0014). In contrast, IL-8 rs4073 and rs2227306 polymorphisms showed no statistically significant associations with mortality when analyzed individually. Multilocus genotype combination analysis suggested that specific combinations involving IL-8R1 rs2234671 may influence clinical outcomes, although these findings require further validation. Conclusions: Our findings indicate that the IL-8R1 rs2234671 polymorphism is associated with COVID-19 mortality in the studied Iranian population, supporting the importance of IL-8/CXCR1-mediated inflammatory pathways in disease progression. Although individual IL-8 polymorphisms were not significantly associated with mortality, combined genetic effects may contribute to outcome variability. However, the proposed functional mechanisms remain to be experimentally validated. Larger multi-ethnic studies and functional investigations are needed to validate these associations and clarify their biological significance. Clinical trial number: Not applicable.
- 4 November 2026
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 27 (1)
Open AccessAssociation of IL-8 and IL-8R1 gene polymorphisms with COVID-19 mortality
Background: Host genetic factors contribute to the heterogeneity of clinical outcomes in Coronavirus Disease 2019 (COVID-19). Interleukin-8 (IL-8) and its receptor IL-8R1 (CXCR1) play key roles in inflammatory responses and cytokine-mediated tissue damage during severe SARS-CoV-2 infection. This study investigated the association of IL-8 rs4073 and rs2227306, as well as IL-8R1 rs2234671 polymorphisms, with COVID-19 mortality in an Iranian population. Methods: A total of 328 hospitalized COVID-19 patients, including 178 recovered and 150 deceased individuals, were enrolled. Genotyping of IL-8 rs4073, IL-8 rs2227306, and IL-8R1 rs2234671 polymorphisms was performed using polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP), and selected samples were confirmed by Sanger sequencing. Genotype and allele frequencies were compared between groups, and logistic regression models were applied to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Multilocus genotype combination analysis was also conducted. Results: The IL-8R1 rs2234671 polymorphism showed a significant association with COVID-19 mortality. Carriers of the G allele exhibited an increased risk of death compared with CC homozygotes under codominant, dominant, overdominant, and log-additive inheritance models (all P < 0.05). The strongest association was observed under the dominant model (OR = 3.29, 95% CI = 1.55–6.99, P = 0.0014). In contrast, IL-8 rs4073 and rs2227306 polymorphisms showed no statistically significant associations with mortality when analyzed individually. Multilocus genotype combination analysis suggested that specific combinations involving IL-8R1 rs2234671 may influence clinical outcomes, although these findings require further validation. Conclusions: Our findings indicate that the IL-8R1 rs2234671 polymorphism is associated with COVID-19 mortality in the studied Iranian population, supporting the importance of IL-8/CXCR1-mediated inflammatory pathways in disease progression. Although individual IL-8 polymorphisms were not significantly associated with mortality, combined genetic effects may contribute to outcome variability. However, the proposed functional mechanisms remain to be experimentally validated. Larger multi-ethnic studies and functional investigations are needed to validate these associations and clarify their biological significance. Clinical trial number: Not applicable.
- 1 June 2026
- Published by Springer Nature in Antonie van Leeuwenhoek
- Vol. 119 (7) , 137
A bioactive pigment from violet-hued bacteria: a dual approach against prostate cancer and bacterial infections
Given the high potential of microbial metabolites, including pigments, and the desire to utilize them in pharmaceuticals, we decided to isolate the violacein pigment from its producing bacteria and investigate its antioxidant, antimicrobial, and anticancer properties in a PC3 cell line. The bacterium that produces the violacein pigment was isolated from the soil and identified through 16S rRNA sequencing. The pigment was extracted using absolute ethanol. After confirming the pigment, its antimicrobial, antioxidant, and anticancer activities were evaluated using MTT, flow cytometry with apoptosis and cell cycle assays in the PC3 cell line. The violacein-producing bacterium has been identified and named Janthinobacterium lividum strain BAH 1. This pigment was found to have a more significant effect on Gram-positive bacteria; specifically, its highest impact, at a concentration of 1 mg mL−1, was observed with Streptococcus mutans, which exhibited a growth inhibition zone of 25.5 mm in the disk diffusion method, compared to Gram-negative bacteria. Its highest free radical inhibition was 67%. The IC50 for the PC3 cell line after 48 h was 4.30 µg mL−1, indicating a more potent lethal effect than on HFF cells. An increase in cells in the sub-G1 phase (48.79%), along with a total apoptosis rate of 75.84% in the treatment group, signifies cell death. Overall, the findings showed that violacein is a promising bioactive compound with potential applications in antibacterial, anticancer, and antioxidant studies. Graphical abstract The alternative text for this image may have been generated using AI.
- 1 June 2026
- Published by Springer Nature in Antonie van Leeuwenhoek
- Vol. 119 (7) , 137
A bioactive pigment from violet-hued bacteria: a dual approach against prostate cancer and bacterial infections
Given the high potential of microbial metabolites, including pigments, and the desire to utilize them in pharmaceuticals, we decided to isolate the violacein pigment from its producing bacteria and investigate its antioxidant, antimicrobial, and anticancer properties in a PC3 cell line. The bacterium that produces the violacein pigment was isolated from the soil and identified through 16S rRNA sequencing. The pigment was extracted using absolute ethanol. After confirming the pigment, its antimicrobial, antioxidant, and anticancer activities were evaluated using MTT, flow cytometry with apoptosis and cell cycle assays in the PC3 cell line. The violacein-producing bacterium has been identified and named Janthinobacterium lividum strain BAH 1. This pigment was found to have a more significant effect on Gram-positive bacteria; specifically, its highest impact, at a concentration of 1 mg mL−1, was observed with Streptococcus mutans, which exhibited a growth inhibition zone of 25.5 mm in the disk diffusion method, compared to Gram-negative bacteria. Its highest free radical inhibition was 67%. The IC50 for the PC3 cell line after 48 h was 4.30 µg mL−1, indicating a more potent lethal effect than on HFF cells. An increase in cells in the sub-G1 phase (48.79%), along with a total apoptosis rate of 75.84% in the treatment group, signifies cell death. Overall, the findings showed that violacein is a promising bioactive compound with potential applications in antibacterial, anticancer, and antioxidant studies. Graphical abstract The alternative text for this image may have been generated using AI.
- Open Access
- 26 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
In vitro assessment of an antimicrobial peptide against Acinetobacter baumannii persister cells
The rise of multidrug-resistant and persister cell populations of Acinetobacter baumannii ( A. baumannii ) poses a significant threat in healthcare settings, highlighting the need for novel therapeutic strategies. This study investigates a specifically designed antimicrobial peptide and its potential activity against this pathogen. Using advanced bioinformatics, a 20-amino acid antimicrobial peptide was designed and synthesized. The peptide’s efficacy was evaluated in vitro through MIC assays against A. baumannii , along with assessments of its effects on persister cells, biofilm formation, and gene expression (pmrB and lasI) using quantitative PCR. The designed peptide exhibited a potent MIC value of 64 µg/mL, reducing persister cell populations of A. baumannii by 75% within 24 h (p < 0.0001). It significantly inhibited biofilm formation, with OD reductions of up to 5.4 log at 64 µg/mL (p < 0.0001). Real-time PCR analysis revealed a 6.2-fold upregulation of pmrB and 3.7-fold upregulation of lasI after 24 h (p < 0.0001), indicating bacterial adaptive responses. The antimicrobial peptide demonstrated strong antibacterial and antibiofilm activity against A. baumannii , though with moderate cytotoxicity (8–17% reduction in cell viability). These findings suggest a promising avenue for developing novel antimicrobial strategies.
- 26 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessIn vitro assessment of an antimicrobial peptide against Acinetobacter baumannii persister cells
The rise of multidrug-resistant and persister cell populations of Acinetobacter baumannii ( A. baumannii ) poses a significant threat in healthcare settings, highlighting the need for novel therapeutic strategies. This study investigates a specifically designed antimicrobial peptide and its potential activity against this pathogen. Using advanced bioinformatics, a 20-amino acid antimicrobial peptide was designed and synthesized. The peptide’s efficacy was evaluated in vitro through MIC assays against A. baumannii , along with assessments of its effects on persister cells, biofilm formation, and gene expression (pmrB and lasI) using quantitative PCR. The designed peptide exhibited a potent MIC value of 64 µg/mL, reducing persister cell populations of A. baumannii by 75% within 24 h (p < 0.0001). It significantly inhibited biofilm formation, with OD reductions of up to 5.4 log at 64 µg/mL (p < 0.0001). Real-time PCR analysis revealed a 6.2-fold upregulation of pmrB and 3.7-fold upregulation of lasI after 24 h (p < 0.0001), indicating bacterial adaptive responses. The antimicrobial peptide demonstrated strong antibacterial and antibiofilm activity against A. baumannii , though with moderate cytotoxicity (8–17% reduction in cell viability). These findings suggest a promising avenue for developing novel antimicrobial strategies.
- Open Access
- 7 October 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (10) , e0227024
Emergence of Escherichia coli sequence type 131 clone carrying bla CTX-M genes in Guilan Province, Northern Iran
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales complicate clinical management, as they are resistant to standard antibiotics and often necessitate intricate treatment plans. As a result, continuous monitoring is essential to prevent the spread of resistant strains and ensure effective treatment options are available. Enterobacterales are humans’ primary contributors to urinary tract infections (UTIs). Among these, Escherichia coli ( E. coli ) sequence type 131 (ST131), which carries β-lactamase genes with significant virulence potential, has been documented globally. E. coli ST131 mostly belongs to the serotypes O25 and O16 and is a well-defined subclone of the FimH30 and FimH30-Rx. We aimed to evaluate the impact of the ST131 clone carrying three β-lactamase genes—the bla CTX-M-1 , bla CTX-M-14 , and bla CTX-M-15 genes—in the antibiotic resistance pattern of ESBL-producing E. coli (ESBL-EC) from UTIs in Guilan, Iran. The phenotypic confirmatory disc diffusion test (PCDDT), according to CLSI recommendations, was utilized to detect ESBL production. The ESBL-EC isolates were screened for the ST131 clone using specific PCR of O25b, O16, H30, and H30-Rx. Out of the 107 ESBL-EC, 70 (65.4%) showed as ST131. Among the ST131 clones, the highest frequency belonged to the ST131-H30 (98.6%). Among the beta-lactam antibiotics, both the ST131 and non-ST131 groups exhibited complete resistance (100%) to cefotaxime, ampicillin, amoxicillin-clavulanate, cephalothin, cefixime, and ceftriaxone while demonstrating the greatest susceptibility to imipenem ( R = 0%). In the case of non-beta-lactam antibiotics, both groups showed significant resistance (approximately 91%) to nalidixic acid, while displaying the highest susceptibility to nitrofurantoin (up to 83%). Our study confirmed the dominance of the ST131 clone among the ESBL-EC and β-lactamase genes associated with the transmission of this pandemic clone. IMPORTANCE: Various antibiotic resistance and virulence genes highlight challenges in clinical management and emphasize the need for effective treatment strategies to reduce the risks associated with UTIs. Continuous research is essential to improve knowledge and create innovative approaches to tackle these urological conditions. Our study confirmed the predominance of genes related to the ST131 clone, including O25, O16, H30, and H30-Rx, among ESBL-EC. We found that the E. coli ST131 clone carried bla CTX-M-1 , bla CTX-M-14 , and bla CTX-M-15 and was expanded in our locale. The clones differed significantly in resistance, susceptibility, and relative susceptibility, only in antibiotic resistance in the case of nitrofurantoin ( P < 0.001). Combining resistance genes in the ST131 clone can facilitate its rapid and successful global spread.
- 7 October 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (10) , e0227024
Open AccessEmergence of Escherichia coli sequence type 131 clone carrying bla CTX-M genes in Guilan Province, Northern Iran
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales complicate clinical management, as they are resistant to standard antibiotics and often necessitate intricate treatment plans. As a result, continuous monitoring is essential to prevent the spread of resistant strains and ensure effective treatment options are available. Enterobacterales are humans’ primary contributors to urinary tract infections (UTIs). Among these, Escherichia coli ( E. coli ) sequence type 131 (ST131), which carries β-lactamase genes with significant virulence potential, has been documented globally. E. coli ST131 mostly belongs to the serotypes O25 and O16 and is a well-defined subclone of the FimH30 and FimH30-Rx. We aimed to evaluate the impact of the ST131 clone carrying three β-lactamase genes—the bla CTX-M-1 , bla CTX-M-14 , and bla CTX-M-15 genes—in the antibiotic resistance pattern of ESBL-producing E. coli (ESBL-EC) from UTIs in Guilan, Iran. The phenotypic confirmatory disc diffusion test (PCDDT), according to CLSI recommendations, was utilized to detect ESBL production. The ESBL-EC isolates were screened for the ST131 clone using specific PCR of O25b, O16, H30, and H30-Rx. Out of the 107 ESBL-EC, 70 (65.4%) showed as ST131. Among the ST131 clones, the highest frequency belonged to the ST131-H30 (98.6%). Among the beta-lactam antibiotics, both the ST131 and non-ST131 groups exhibited complete resistance (100%) to cefotaxime, ampicillin, amoxicillin-clavulanate, cephalothin, cefixime, and ceftriaxone while demonstrating the greatest susceptibility to imipenem ( R = 0%). In the case of non-beta-lactam antibiotics, both groups showed significant resistance (approximately 91%) to nalidixic acid, while displaying the highest susceptibility to nitrofurantoin (up to 83%). Our study confirmed the dominance of the ST131 clone among the ESBL-EC and β-lactamase genes associated with the transmission of this pandemic clone. IMPORTANCE: Various antibiotic resistance and virulence genes highlight challenges in clinical management and emphasize the need for effective treatment strategies to reduce the risks associated with UTIs. Continuous research is essential to improve knowledge and create innovative approaches to tackle these urological conditions. Our study confirmed the predominance of genes related to the ST131 clone, including O25, O16, H30, and H30-Rx, among ESBL-EC. We found that the E. coli ST131 clone carried bla CTX-M-1 , bla CTX-M-14 , and bla CTX-M-15 and was expanded in our locale. The clones differed significantly in resistance, susceptibility, and relative susceptibility, only in antibiotic resistance in the case of nitrofurantoin ( P < 0.001). Combining resistance genes in the ST131 clone can facilitate its rapid and successful global spread.
- 17 August 2025
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 61 (5) , 889-897
In Vitro Efficacy of Nisin Peptide on Biofilm Formation and Cell Invasion of Listeria monocytogenes
This study investigated the effects of nisin concentrations on the biofilm formation and cellular invasion of Listeria monocytogenes. The study also examined the toxicity of nisin concentrations on human cell lines. Nisin is a lantibiotic with antimicrobial properties. L. monocytogenes is a deadly foodborne pathogen leading to listeriosis. Biofilm formation, cell invasion, toxin-antitoxin systems, and extracellular proteins are the primary virulence mechanisms of L. monocytogenes. The PCR method was used to confirm the presence of virulence genes in L. monocytogenes. A microplate assay was used for biofilm quantification. The effect of nisin on cell invasion and cytotoxicity in the HT-29 human cell line was investigated using invasion assay and thiazolyl blue tetrazolium bromide (MTT) methods, respectively. Nisin solutions of 104, 103, and 102 IU/mL inhibited biofilm formation by 56, 90, and 99%, respectively (p < 0.0001). Nisin at concentration of 102 IU/mL reduced the expression of biofilm formation genes: 2.5-fold for mazF, 3.9-fold for flaA, and 3.4-fold for cheA. However, the increased iap gene expression (p < 0.0001) observed at nisin of 102 IU/mL. Nisin solutions of 104, 103, and 102 IU/mL reduced the invasion into HT-29 cells by 42, 73, and 99%, respectively. Survival of the HT-29 cells treated with nisin solutions of 104, 103, and 102 IU/mL decreased by 2, 7, and 18%, respectively. The action of nisin can be enhanced through various innovative techniques, increasing its effectiveness against L. monocytogenes. Nisin significantly inhibited the expression of genes involved in biofilm formation, cell invasion, and cellular signal transduction in L. monocytogenes.
- 17 August 2025
- Published by Pleiades Publishing Ltd in Applied Biochemistry and Microbiology
- Vol. 61 (5) , 889-897
In Vitro Efficacy of Nisin Peptide on Biofilm Formation and Cell Invasion of Listeria monocytogenes
This study investigated the effects of nisin concentrations on the biofilm formation and cellular invasion of Listeria monocytogenes. The study also examined the toxicity of nisin concentrations on human cell lines. Nisin is a lantibiotic with antimicrobial properties. L. monocytogenes is a deadly foodborne pathogen leading to listeriosis. Biofilm formation, cell invasion, toxin-antitoxin systems, and extracellular proteins are the primary virulence mechanisms of L. monocytogenes. The PCR method was used to confirm the presence of virulence genes in L. monocytogenes. A microplate assay was used for biofilm quantification. The effect of nisin on cell invasion and cytotoxicity in the HT-29 human cell line was investigated using invasion assay and thiazolyl blue tetrazolium bromide (MTT) methods, respectively. Nisin solutions of 104, 103, and 102 IU/mL inhibited biofilm formation by 56, 90, and 99%, respectively (p < 0.0001). Nisin at concentration of 102 IU/mL reduced the expression of biofilm formation genes: 2.5-fold for mazF, 3.9-fold for flaA, and 3.4-fold for cheA. However, the increased iap gene expression (p < 0.0001) observed at nisin of 102 IU/mL. Nisin solutions of 104, 103, and 102 IU/mL reduced the invasion into HT-29 cells by 42, 73, and 99%, respectively. Survival of the HT-29 cells treated with nisin solutions of 104, 103, and 102 IU/mL decreased by 2, 7, and 18%, respectively. The action of nisin can be enhanced through various innovative techniques, increasing its effectiveness against L. monocytogenes. Nisin significantly inhibited the expression of genes involved in biofilm formation, cell invasion, and cellular signal transduction in L. monocytogenes.
- 28 February 2025
- Published by Elsevier in Gene Reports
- Vol. 39
LncRNAs PVT1, HULC, and HOTTIP: A promising biomarker trio for diffuse large B-cell lymphoma
- 28 February 2025
- Published by Elsevier in Gene Reports
- Vol. 39
LncRNAs PVT1, HULC, and HOTTIP: A promising biomarker trio for diffuse large B-cell lymphoma
- Open Access
The PVT1, HULC, and HOTTIP expression changes due to treatment in Diffuse Large B-cell lymphoma
Diffuse large B-cell lymphoma is the most common histological subtype of non-Hodgkin’s lymphomas. It is an aggressive malignancy that displays great heterogeneity in morphology, genetics, biological behavior and treatment response owing to chromatin remodeling and epigenetics. Bioinformatic-based approaches were used to understand the possible signaling pathways of the three lncRNAs PVT1 , HULC , and HOTTIP . Furthermore, their expression levels were quantitatively evaluated in 100 patients before and after the treatment. The results revealed that gene expression was significantly upregulated in PVT1 , HULC , and HOTTIP by 7.39±8.48-, 5.924±7.536-, and 4.137±5.863 fold, respectively, relative to normal cases. Post-treatment measurement of lncRNA expression indicated that PVT1 and HOTTIP were significantly downregulated. Interestingly, the expression levels of PVT1 , HULC , and HOTTIP were significantly higher in DLBCL patients aged > 60 years than in those aged < 60 years. In addition, there was a significant positive correlation between HULC and HOTTIP expression. The analysis of overexpressed lncRNA-miRNA interaction indicated different deregulated miRNA targets and the protein targets of upregulated lncRNAs are mainly with histone modification, DNA methylation/demethylation, and protein methyltransferase activity. Summary blurb: The lncRNAs PVT1 , HULC , and HOTTIP expression is significantly upregulated before treatment and reduce to normal level after treatment. It can be used as diagnostic marker or prognostic means especially in Relapsed/refractory DLBCL.
Open AccessThe PVT1, HULC, and HOTTIP expression changes due to treatment in Diffuse Large B-cell lymphoma
Diffuse large B-cell lymphoma is the most common histological subtype of non-Hodgkin’s lymphomas. It is an aggressive malignancy that displays great heterogeneity in morphology, genetics, biological behavior and treatment response owing to chromatin remodeling and epigenetics. Bioinformatic-based approaches were used to understand the possible signaling pathways of the three lncRNAs PVT1 , HULC , and HOTTIP . Furthermore, their expression levels were quantitatively evaluated in 100 patients before and after the treatment. The results revealed that gene expression was significantly upregulated in PVT1 , HULC , and HOTTIP by 7.39±8.48-, 5.924±7.536-, and 4.137±5.863 fold, respectively, relative to normal cases. Post-treatment measurement of lncRNA expression indicated that PVT1 and HOTTIP were significantly downregulated. Interestingly, the expression levels of PVT1 , HULC , and HOTTIP were significantly higher in DLBCL patients aged > 60 years than in those aged < 60 years. In addition, there was a significant positive correlation between HULC and HOTTIP expression. The analysis of overexpressed lncRNA-miRNA interaction indicated different deregulated miRNA targets and the protein targets of upregulated lncRNAs are mainly with histone modification, DNA methylation/demethylation, and protein methyltransferase activity. Summary blurb: The lncRNAs PVT1 , HULC , and HOTTIP expression is significantly upregulated before treatment and reduce to normal level after treatment. It can be used as diagnostic marker or prognostic means especially in Relapsed/refractory DLBCL.
- Open Access
- 1 December 2023
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 17 (6) , 629-637
Antibiotic Resistance Pattern and Prevalence of Virulence Factors among ESBLs-producing Escherichia coli Isolates Causing Urinary Tract Infections
Background and Aim: Urinary tract infections (UTIs) pose a significant global health threat, primarily attributed to bacteria producing extended-spectrum beta-lactamases (ESBLs), with limited treatment options available. The specific genotypes of ESBL-producing strains remain largely unexplored in Guilan (northern Iran). Hence, the objective of this study was to determine the prevalence of ESBL-producing ...
- 1 December 2023
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 17 (6) , 629-637
Open AccessAntibiotic Resistance Pattern and Prevalence of Virulence Factors among ESBLs-producing Escherichia coli Isolates Causing Urinary Tract Infections
Background and Aim: Urinary tract infections (UTIs) pose a significant global health threat, primarily attributed to bacteria producing extended-spectrum beta-lactamases (ESBLs), with limited treatment options available. The specific genotypes of ESBL-producing strains remain largely unexplored in Guilan (northern Iran). Hence, the objective of this study was to determine the prevalence of ESBL-producing ...
- Open Access
- 13 June 2023
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 16 (4)
Expression of Biofilm-Related Genes in Extensively Drug-Resistant Acinetobacter baumannii
Background: Acinetobacter baumannii is an important cause of nosocomial pneumonia in patients requiring long-term mechanical ventilation. Besides, extensively drug-resistant (XDR) strains cause infection in intensive care unit (ICU) patients. Chronic infections of A. baumannii and antimicrobial resistance are associated with biofilm formation. Several virulence genes, such as blaPER-1, pgaA, and bap, are involved in biofilm formation. Objectives: The current study examines the expression levels of biofilm formation-related genes in pneumonia patients. Methods: The sputum samples were collected from patients hospitalized in the ICU, and A. baumannii ATCC 19606, the reference strain, was isolated and cultured on blood agar, eosin methylene blue agar, and chocolate agar medium. The media were then incubated at 37°C for 18 - 24 hours. Next, Gram-Thirty XDR A. baumannii isolates were collected from the sputum samples of ICU patients at Besat Hospital in Tehran, Iran. Bacterial isolates were characterized for antibiotic resistance patterns and biofilm-forming ability. Subsequently, RNA was extracted from the biofilm-forming isolates. A real-time polymerase chain reaction (PCR) assay was performed to evaluate the expression levels of the blaPER-1, pgaA, and bap genes. Transcripts were normalized to 16S rRNA as an internal control, and gene expression fold changes were calculated. Statistical analysis was performed using an unpaired two-tailed t-test (P < 0.05) with SPSS (V. 16). Results: The disk diffusion susceptibility test revealed that all 30 (100%) isolates were resistant to piperacillin-tazobactam, cefepime, ceftriaxone, ceftazidime, gentamicin, imipenem, meropenem, levofloxacin, and ciprofloxacin. All 30 isolates from ICU-admitted patients (100%) were classified as XDR, and 27 (90%) isolates demonstrated the ability to form biofilms. The obtained results indicated a significant difference in gene expression levels. The fold change in expression for blaPER-1, bap, and pgaA was 7.473, 11.964, and 5.277, respectively. Conclusions: In our study, XDR A. baumannii primarily caused ventilator-associated pneumonia, and an observed increase in the expression of biofilm-related genes was noted in these strains. Healthcare centers should implement appropriate infection control programs to manage nosocomial infections, particularly in the ICU.
- 13 June 2023
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 16 (4)
Open AccessExpression of Biofilm-Related Genes in Extensively Drug-Resistant Acinetobacter baumannii
Background: Acinetobacter baumannii is an important cause of nosocomial pneumonia in patients requiring long-term mechanical ventilation. Besides, extensively drug-resistant (XDR) strains cause infection in intensive care unit (ICU) patients. Chronic infections of A. baumannii and antimicrobial resistance are associated with biofilm formation. Several virulence genes, such as blaPER-1, pgaA, and bap, are involved in biofilm formation. Objectives: The current study examines the expression levels of biofilm formation-related genes in pneumonia patients. Methods: The sputum samples were collected from patients hospitalized in the ICU, and A. baumannii ATCC 19606, the reference strain, was isolated and cultured on blood agar, eosin methylene blue agar, and chocolate agar medium. The media were then incubated at 37°C for 18 - 24 hours. Next, Gram-Thirty XDR A. baumannii isolates were collected from the sputum samples of ICU patients at Besat Hospital in Tehran, Iran. Bacterial isolates were characterized for antibiotic resistance patterns and biofilm-forming ability. Subsequently, RNA was extracted from the biofilm-forming isolates. A real-time polymerase chain reaction (PCR) assay was performed to evaluate the expression levels of the blaPER-1, pgaA, and bap genes. Transcripts were normalized to 16S rRNA as an internal control, and gene expression fold changes were calculated. Statistical analysis was performed using an unpaired two-tailed t-test (P < 0.05) with SPSS (V. 16). Results: The disk diffusion susceptibility test revealed that all 30 (100%) isolates were resistant to piperacillin-tazobactam, cefepime, ceftriaxone, ceftazidime, gentamicin, imipenem, meropenem, levofloxacin, and ciprofloxacin. All 30 isolates from ICU-admitted patients (100%) were classified as XDR, and 27 (90%) isolates demonstrated the ability to form biofilms. The obtained results indicated a significant difference in gene expression levels. The fold change in expression for blaPER-1, bap, and pgaA was 7.473, 11.964, and 5.277, respectively. Conclusions: In our study, XDR A. baumannii primarily caused ventilator-associated pneumonia, and an observed increase in the expression of biofilm-related genes was noted in these strains. Healthcare centers should implement appropriate infection control programs to manage nosocomial infections, particularly in the ICU.
- 1 October 2021
- Published by Allerton Press in Molecular Genetics, Microbiology and Virology
- Vol. 36 (4) , 210-219
Evaluation of Antimicrobial Activity of Iron Oxide Nanoparticles on Biofilm Production and Antibiotic Resistance in Acinetobacter baumannii Strains
Purpose: Acinetobacter baumannii (A. baumannii) is an opportunistic human pathogen that clinically causes important infections in patients mainly due to in
- 1 October 2021
- Published by Allerton Press in Molecular Genetics, Microbiology and Virology
- Vol. 36 (4) , 210-219
Evaluation of Antimicrobial Activity of Iron Oxide Nanoparticles on Biofilm Production and Antibiotic Resistance in Acinetobacter baumannii Strains
Purpose: Acinetobacter baumannii (A. baumannii) is an opportunistic human pathogen that clinically causes important infections in patients mainly due to in